Update on the types and usage of liquid biopsies in the clinical setting: a systematic review

Circulating Tumor DNA as Biomarkers for Cancer Detection

(2017) Xiao Han et al.   GENOMICS PROTEOMICS & BIOINFORMATICS

Liquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB)

(2016) Michael Tu et al.   ANALYST

Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis

(2016) Pamela J. Kaisaki et al.   PLoS One

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing

(2016) Inga Medina Diaz et al.   PLoS One

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

(2015) T. Mok et al.   CLINICAL CANCER RESEARCH

KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives

(2015) N. Guibert et al.   CURRENT MOLECULAR MEDICINE

Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?

(2015) Bert Gold et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer

(2015) Friederike Braig et al.   Oncotarget

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

(2015) Filip Janku et al.   Oncotarget

ESR1gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients

(2014) Joaquina Martínez-Galán et al.   BMC CANCER

Double-stranded DNA in exosomes: a novel biomarker in cancer detection

(2014) Basant Kumar Thakur et al.   CELL RESEARCH

Circulating Tumor DNA as a Liquid Biopsy for Cancer

(2014) E. Heitzer et al.   CLINICAL CHEMISTRY

Liquid Biopsies: Genotyping Circulating Tumor DNA

(2014) Luis A. Diaz et al.   JOURNAL OF CLINICAL ONCOLOGY

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

(2014) Aaron M Newman et al.   NATURE MEDICINE

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

(2014) E. C. de Bruin et al.   SCIENCE

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Next generation sequencing in cancer research and clinical application

(2013) Derek Shyr et al.   BIOLOGICAL PROCEDURES ONLINE

Circulating cell free DNA: Preanalytical considerations

(2013) Safia El Messaoudi et al.   CLINICA CHIMICA ACTA

Genomic Medicine: New Frontiers and New Challenges

(2013) M. D. Pasic et al.   CLINICAL CHEMISTRY

Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer

(2013) Timothy Robert Church et al.   GUT

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies

(2013) Xiaoqing Liu et al.   JOURNAL OF CLINICAL PATHOLOGY

microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer

(2013) Riccardo Cazzoli et al.   Journal of Thoracic Oncology

Liquid biopsy: monitoring cancer-genetics in the blood

(2013) Emily Crowley et al.   Nature Reviews Clinical Oncology

Circulating Tumor DNA to Monitor Metastatic Breast Cancer

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?

(2013) Evelyn Kidess et al.   Genome Medicine

Hide and seek: tell-tale signs of breast cancer lurking in the blood

(2012) David S. Guttery et al.   CANCER AND METASTASIS REVIEWS

Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer

(2012) Elīna Zandberga et al.   GENES CHROMOSOMES & CANCER

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

(2012) Luis A. Diaz Jr et al.   NATURE

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

(2012) Marco Gerlinger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage I–IV Non-Small Cell Lung Cancer Patients

(2012) Xiao Zhao et al.   RESPIRATION

Circulating tumour markers can define patients with normal colons, benign polyps and cancers

(2011) R Mead et al.   BRITISH JOURNAL OF CANCER

Outcomes of Small Renal Mass Needle Core Biopsy, Nondiagnostic Percutaneous Biopsy, and the Role of Repeat Biopsy

(2011) Michael J. Leveridge et al.   EUROPEAN UROLOGY

The Penetration of Renal Mass Biopsy in Daily Practice: A Survey Among Urologists

(2011) Kurdo Barwari et al.   JOURNAL OF ENDOUROLOGY

Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010

(2011) Benjamin O Anderson et al.   LANCET ONCOLOGY

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer

(2011) John D. O’Flaherty et al.   LUNG CANCER

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

(2010) Marie Brevet et al.   LUNG CANCER

Personalized Medicine: Marking a New Epoch in Cancer Patient Management

(2010) M. Diamandis et al.   MOLECULAR CANCER RESEARCH

Circulating tumour cells: their utility in cancer management and predicting outcomes

(2010) Matthew G. Krebs et al.   Therapeutic Advances in Medical Oncology

Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy

(2009) Richard A. Schwarz et al.   CANCER

Cancer genome sequencing: a review

(2009) E. R. Mardis et al.   HUMAN MOLECULAR GENETICS

Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

(2009) Elaine R. Mardis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sustained lower rates of breast cancer in the United States

(2008) Kathleen A. Cronin et al.   BREAST CANCER RESEARCH AND TREATMENT

Model-based spectroscopic analysis of the oral cavity: impact of anatomy

(2008) Sasha McGee et al.   JOURNAL OF BIOMEDICAL OPTICS

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE